Home
Conditions
Chronic Lymphocytic Leukemia

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

526 public trials 91 recruiting studies

Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Not Yet Recruiting

Biological and Clinical Efficacy of Shingrix in Patients With CLL

NCT06364033

Conditions: CLL-like MBL, Chronic Disease, Chronic Lymphocytic Leukemia, +17 more
Locations: UOC Ematologia ASST dei Sette Laghi Varese, Italy

View Trial Details

Not Yet Recruiting

Familial B-cell Lymphoproliferative Disorders

NCT05718986

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

NCT06367374

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens

NCT04790045

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

NCT05899543

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Completed

Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

NCT02337829

Conditions: Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
Locations: Research Site Bethesda, Maryland, United States

View Trial Details

Completed

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

NCT03480360

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +33 more
Locations: Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States

View Trial Details

Completed

ALICIA (Acalabrutinib in CLL Therapy)

NCT04746950

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Research Site Ufa, Bashkortostan Republic, Russia

Research Site Kaliningrad, Kaliningrad Oblast, Russia

Research Site Khabarovsk, Khabarovskiy Kray, Russia

Research Site Syktyvkar, Komi, Russia

View all 15 locations

View Trial Details

Completed

Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

NCT03447808

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

NCT04502030

Conditions: Agammaglobulinemia, Blood Protein Disorders, Chronic Disease, +18 more
Locations: Octapharma Research Site St. Petersburg, Florida, United States

Octapharma Research Site Columbus, Georgia, United States

Octapharma Research Site Macon, Georgia, United States

Octapharma Research Site New Orleans, Louisiana, United States

View all 84 locations

View Trial Details

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia trial results

Related conditions